News Microbiotica MB097 Shows Promise in Melanoma Trial Microbiotica reports positive Phase 1b data for MB097, a precision microbiome co-therapy combined with pembrolizumab in advanced melanoma patients.
News Gut Microbiome Metabolites Modulate Cancer Immunotherapy A Nature Communications review finds gut microbiome metabolites modulate cancer immunotherapy response by targeting both the immune system and tumour cells.
News Gut Microbiome Linked to Cancer Immunotherapy Side Effects A new Nature study links the gut microbiome to immune-related adverse events in cancer immunotherapy, suggesting microbial health shapes treatment safety.
